Glenda M. Macqueen
3280 Hospital Dr NW
Calgary, AB T2N4Z6, Canada
Calgary, AB T2N4Z6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 172 publications
Prediction modeling in transdiagnostic risk: results from the PROCAN study.
Journal: Brain imaging and behavior
Published: July 02, 2025
Brain connectomes in youth at risk for serious mental illness: a longitudinal perspective.
Journal: Brain imaging and behavior
Published: October 25, 2024
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder.
Journal: BJPsych open
Published: January 05, 2024
Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study.
Journal: Research square
Published: October 27, 2023
An empirical analysis of structural neuroimaging profiles in a staging model of depression.
Journal: Journal of affective disorders
Published: October 12, 2023
Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study.
Journal: IBRO neuroscience reports
Published: September 24, 2023
Factors Associated with Transition to Serious Mental Illness.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: August 22, 2023
Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study.
Journal: Translational psychiatry
Published: August 12, 2023
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report.
Journal: CNS spectrums
Published: May 23, 2023
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: February 14, 2023
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: June 17, 2022
Last Updated: 09/26/2026